<DOC>
	<DOCNO>NCT01171456</DOCNO>
	<brief_summary>Gestational diabetes ( GDM ) represent significant grow source nationwide morbidity mortality mother infant . Between 5 10 % pregnancy complicate GDM . Infants expose utero hyperglycemia GDM increase risk neonatal complication well increase prevalence number chronic disease , include type 2 diabetes schizophrenia . Recent research show treatment metformin begin soon hyperglycemia detected pregnancy safe effective . Additional study demonstrate metformin able decrease incidence type 2 diabetes among individual risk disease . Based upon finding , investigator propose test hypothesis metformin therapy woman risk gestational diabetes , start prior conception onset hyperglycemia , decrease incidence improve maternal neonatal outcome GDM . The investigator intend conduct prospective , randomize , double-blind placebo control range-finding study measure effect early metabolic intervention metformin woman risk GDM commencement pregnancy prior completion first trimester . The target sample size pilot study 100 woman . The effect size observe provide preliminary data subsequent study sufficiently power detect small moderate effect early metabolic intervention woman risk GDM . The specific aim propose research consist follow : 1 . Determine whether treat woman risk GDM metformin prior conception and/or completion 1st trimester decrease incidence GDM 26 week ' gestation . 2 . Evaluate effect maternal fetal pregnancy outcomes pre-conception metabolic intervention metformin woman risk GDM . 3 . Use pilot study result : 1. identify specific demographic characteristic associate intervention effect 2. calculate effect size specific outcomes 3. provide range-finding data subsequent study design Metformin therapy woman risk gestational diabetes , start prior conception onset hyperglycemia , decrease incidence improve maternal neonatal outcome GDM .</brief_summary>
	<brief_title>Early Intervention Gestational Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Women deliver &gt; 37 week gestation Intermountain Healthcare Urban Central Region within last 18 month ascertain risk GDM next pregnancy : A history gestational diabetes immediately prior pregnancy A family history ( i.e . type 2 diabetes first second degree relative ) type 2 diabetes Delivery infant &gt; 4000 gm . B.M.I . &gt; 30 six month postpartum Hemoglobin A1C &gt; 6.1 % six month postpartum Preconception exclusion criterion include follow : History &gt; 1 miscarriage fetal demise No contraindication metformin ( prior metformin intolerance , metabolic acidosis , GI disease ) Hypertension ( BP &gt; 135/85 ) No endocrine , metabolic , renal , autommune medical disorder Prior preterm birth Prior delivery complicate shoulder dystocia Prior delivery complicate neonatal palsy Multifetal pregnancy , include firsttrimester embryonic demise one Uterine malformation Illicit drug alcohol abuse current pregnancy Intent deliver elsewhere Nonavailability prospective specimen/data collection</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>GDM</keyword>
	<keyword>Gestational Diabetes</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Pregnancy</keyword>
</DOC>